Relationship Between Immunophenotypes, Genetic Profiles, and Clinicopathologic Characteristics in Small Bowel Adenocarcinoma
Authors:
Open Access
- 4 December 2023
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 48 (2) , 127-139
Abstract
Small bowel adenocarcinoma (SBA) is rare, and scant data exist regarding its molecular and clinicopathologic characteristics. This study aimed to clarify the correlation between immunophenotypes, DNA mismatch repair status, genomic profiling, and clinicopathologic characteristics in patients with SBA. We examined 68 surgical resections from patients with primary SBA for immunohistochemical analyses of CK7, CK20, CD10, CDX2, MUC1, MUC2, MUC4, MUC5AC, and MUC6 expression as well as mismatch repair status. Genomic profiling was performed on 30 cases using targeted next-generation sequencing. Tumor mucin phenotypes were classified as gastric, intestinal, gastrointestinal, or null based on MUC2, MUC5AC, MUC6, and CD10 immunostaining. The expression of these proteins was categorized into 3 classifications according to their relationship to: (1) tumor location: CK7/CK20, MUC4, and MUC6; (2) histologic type: mucinous adenocarcinoma was positive for MUC2 and negative for MUC6; and (3) TNM stage: CD10 was downregulated, whereas MUC1 was upregulated in advanced TNM stages. CDX2 was a specific marker for SBA generally expressed in the small intestine. MUC1 and MUC4 expression was significantly associated with worse prognosis. MUC2 expression correlated with better prognosis, except for mucinous adenocarcinoma. Although the difference was not statistically significant, gastric-type tumors were more frequently located in the duodenum and were absent in the ileum. APC and CTNNB1 mutations were not found in the gastric-type tumors. The SBA immunophenotype correlated with tumor location, biological behavior, and genomic alterations. Our results suggest that the molecular pathway involved in carcinogenesis of gastric-type SBA differs from that of intestinal-type SBA.Keywords
This publication has 37 references indexed in Scilit:
- Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinomaLaboratory Investigation, 2014
- Pathobiological Implications of Mucin (MUC) Expression in the Outcome of Small Bowel CancerPLOS ONE, 2014
- Prognostic value of lymph node evaluation in small bowel adenocarcinomaCancer, 2010
- Immunophenotype and molecular characterisation of adenocarcinoma of the small intestineBritish Journal of Cancer, 2009
- Expression of Mucins, SIMA, Villin, and CDX2 in Small-Intestinal AdenocarcinomaAmerican Journal of Clinical Pathology, 2007
- Human MUC2 Mucin Gene Is Transcriptionally Regulated by Cdx Homeodomain Proteins in Gastrointestinal Carcinoma Cell LinesJournal of Biological Chemistry, 2003
- Expression of Mucins and Cytokeratins in Primary Carcinomas of the Digestive SystemLaboratory Investigation, 2003
- Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2Science, 2002
- Gastric-type adenocarcinoma of the duodenal second portion histogenetically associated with hyperplasia and gastric-foveolar metaplasia of Brunner's glandsVirchows Archiv, 2002
- Phenotypic Expression of Colorectal Adenocarcinomas with Reference to Tumor Development and Biological BehaviorJapanese Journal of Cancer Research, 2001